Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Two concurrent mechanisms are responsible for the INa increase produced by dapagliflozin and empagliflozin in healthy and heart failure cardiomyocytes

  • Rapún, Josu
  • Rapún, Josu
  • Pérez-Martín, Sara
  • Pérez-Martín, Sara
  • Cámara-Checa, Anabel
  • Cámara-Checa, Anabel
  • San José, Gorka
  • Núñez-Fernández, Roberto
  • Crespo-García, Teresa
  • Hoban, Adam
  • Rubio-Alarcón, Marcos
  • Martínez-Blanco, Elena
  • Tamargo, Juan
  • Díez-Guerra, F. Javier
  • López, Begoña
  • Gómez, Ricardo
  • González, Arantxa
  • Delpón, Eva
  • Caballero, Ricardo
Dapagliflozin and empagliflozin exert many cardiovascular protective actions in heart failure (HF) patients. HF-induced electrical remodelling decreases the expression of Nav1.5 channels (encoded by SCN5A) that generate the cardiac Na current (I) impairing excitability and promoting arrhythmias. We aimed to mechanistically decipher the peak I increase produced by dapagliflozin and empagliflozin in healthy and HF cardiomyocytes. We recorded macroscopic and single-channel currents and action potentials (AP) using the patch-clamp technique and generated a mouse model of HF with reduced ejection fraction by transverse aortic constriction (TAC). Single-channel recordings showed that dapagliflozin and empagliflozin (1 μM) increased the open probability (P) of Nav1.5 channels by augmenting channel re-openings and the number of traces with openings and by doubling the open time constant, respectively. Both drugs increased SCN5A mRNA levels and the membrane expression of Nav1.5 channels. Empagliflozin also enhanced the cytoplasmic mobility of Nav1.5 channels. Molecular modelling and site-directed mutagenesis analysis demonstrated that both drugs bind to a previously unknown site at the Nav1.5 DIII-DIV fenestration. Dapagliflozin and empagliflozin hyperpolarized the resting membrane potential and increased the action potential amplitude in human cardiomyocytes derived from induced pluripotent stem cells. Importantly, in TAC cardiomyocytes dapagliflozin and empagliflozin restored the HF-reduced peak I to control levels. Dapagliflozin and empagliflozin bind to a novel site within cardiac Nav1.5 increasing I by augmenting the P and the membrane expression of the channels. We hypothesized that this unique effects could be of interest for the treatment of arrhythmias associated with decreased Nav1.5 channel expression., This work was funded by Grants of the Spanish Ministry of Science and Innovation (PID2020–118694RB-I00; PID2023–150993OB-I00), Comunidad de Madrid (ARCADIA S2022/BMD-7229), and Instituto de Salud Carlos III [CB16/11/00303 and CB16/11/00483, and PI21/00946 (AG) co-financed by ERTF funds].
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Generation of Self-Induced Myocardial Ischemia in Large-Sized Cardiac Spheroids without Alteration of Environmental Conditions Recreates Fibrotic Remodeling and Tissue Stiffening Revealed by Constriction Assays

  • Paz-Artigas, Laura
  • González-Lana, Sandra
  • Polo, Nicolás
  • Vicente, Pedro
  • Montero-Calle, Pilar
  • Martínez, Miguel A.
  • Rábago, Gregorio
  • Serra, Margarida
  • Prósper, Felipe
  • Mazo, Manuel M.
  • González, Arantxa
  • Ochoa, Ignacio
  • Ciriza, Jesús
A combination of human-induced pluripotent stem cells (hiPSCs) and 3D microtissue culture techniques allows the generation of models that recapitulate the cardiac microenvironment for preclinical research of new treatments. In particular, spheroids represent the simplest approach to culture cells in 3D and generate gradients of cellular access to the media, mimicking the effects of an ischemic event. However, previous models required incubation under low oxygen conditions or deprived nutrient media to recreate ischemia. Here, we describe the generation of large spheroids (i.e., larger than 500 μm diameter) that self-induce an ischemic core. Spheroids were generated by coculture of cardiomyocytes derived from hiPSCs (hiPSC-CMs) and primary human cardiac fibroblast (hCF). In the proper medium, cells formed aggregates that generated an ischemic core 2 days after seeding. Spheroids also showed spontaneous cellular reorganization after 10 days, with hiPSC-CMs located at the center and surrounded by hCFs. This led to an increase in microtissue stiffness, characterized by the implementation of a constriction assay. All in all, these phenomena are hints of the fibrotic tissue remodeling secondary to a cardiac ischemic event, thus demonstrating the suitability of these spheroids for the modeling of human cardiac ischemia and its potential application for new treatments and drug research.